Celina Liehla Goncalves, DPT | |
55 Lake Ave N, Worcester, MA 01655-0002 | |
(774) 441-8052 | |
(508) 856-4287 |
Full Name | Celina Liehla Goncalves |
---|---|
Gender | Female |
Speciality | Physical Therapist - Pediatrics |
Location | 55 Lake Ave N, Worcester, Massachusetts |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679246110 | NPI | - | NPPES |
Entity Name | Umass Memorial Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760445373 PECOS PAC ID: 4284539891 Enrollment ID: O20040113000267 |
News Archive
In contrast to what has been previously believed, development of blood stem cells to mast cells, a type of specialized immune cell, does not depend on a growth factor called stem cell factor.
A group of researchers from 16 institutions around the world has identified a new class of anti-malarial compounds that target multiple stages of the malaria parasite's life cycle.
An experimental vaccine developed to prevent outbreaks of Marburg hemorrhagic fever continues to show promise in monkeys as an emergency treatment for accidental exposures to the virus that causes the disease. There is no licensed treatment for Marburg infection, which has a high fatality rate.
A robotic walking frame that could help older people recover more quickly after a fall or injury, reducing the length of time they need to stay in hospital, is being developed in partnership with researchers at Northumbria University, Newcastle.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Celina Liehla Goncalves, DPT Po Box 415348, Boston, MA 02241-5348 Ph: (800) 225-8885 | Celina Liehla Goncalves, DPT 55 Lake Ave N, Worcester, MA 01655-0002 Ph: (774) 441-8052 |
News Archive
In contrast to what has been previously believed, development of blood stem cells to mast cells, a type of specialized immune cell, does not depend on a growth factor called stem cell factor.
A group of researchers from 16 institutions around the world has identified a new class of anti-malarial compounds that target multiple stages of the malaria parasite's life cycle.
An experimental vaccine developed to prevent outbreaks of Marburg hemorrhagic fever continues to show promise in monkeys as an emergency treatment for accidental exposures to the virus that causes the disease. There is no licensed treatment for Marburg infection, which has a high fatality rate.
A robotic walking frame that could help older people recover more quickly after a fall or injury, reducing the length of time they need to stay in hospital, is being developed in partnership with researchers at Northumbria University, Newcastle.
› Verified 4 days ago